Psoriasis Triggers Gut Inflammation Through Immune Cell Disruption of Fat Processing

This groundbreaking research solves a medical puzzle by explaining why psoriasis patients face significantly higher risks of developing inflammatory bowel disease, potentially impacting longevity through chronic inflammation pathways.

Researchers studied both human patients and mouse models, discovering that psoriasis severity inversely correlates with the body's ability to process dietary fats after meals. They developed innovative photoconvertible protein reporters to track fat processing in real-time within intestinal cells.

The study revealed that psoriasis promotes expansion of specific immune cells called macrophages in the intestines. These cells produce interleukin-1β, an inflammatory molecule that disrupts normal fat metabolism. The disruption accelerates breakdown of apolipoprotein B, a crucial protein for packaging dietary fats, leading to impaired chylomicron secretion and fat accumulation in intestinal cells.

This metabolic dysfunction creates a cascade of gut inflammation, establishing the mechanistic link between skin and intestinal diseases. The findings suggest that chronic inflammatory conditions may interconnect through shared immune pathways, potentially accelerating aging processes through sustained inflammation.

For longevity optimization, this research highlights how managing one inflammatory condition could prevent others. The identification of intestinal IL-1β as a therapeutic target opens possibilities for interventions that could break the psoriasis-gut inflammation cycle, potentially reducing overall inflammatory burden and supporting healthier aging trajectories.